Radana Bhaskara Finance Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Radana Bhaskara Finance Tbk. trades at Rp86 (market cap 575.74B, 258.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Radana Bhaskara Finance Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 258.6K). Which is the better fit depends on your goals.
| HDFA | LABS | |
|---|---|---|
Market Cap | 575.74B | 584.6B |
Volume | 258.6K | 817.3K |
Lot | 2.59K | 8.17K |
Turnover | 22.27M | 120.01M |
Average Price | 86.12 | 146.84 |
Value | 22.27M | 120.01M |
Indicative Equilibrium Price | 86 | 146 |
Indicative Equilibrium Volume | 200 | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT HD Finance (the company) was incorporated under the name of PT Indonesia Lease Corporation base on notarial deed No.41 of Mr FA Tumbuan, S.H, dated 20 Sep, 1972. The Company's name has been changed from PT HD Finance Tbk to PT Radana Bhaskara Finance Tbk based on the Notarial Deed No. 136 dated May 21, 2014 of Jimmy Tanal, S.H., M.Kn.
Read more on HDFA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →